These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13644653)

  • 21. [Current treatment of peripheral vascular collapse].
    PASSELECQ J
    Presse Med (1893); 1959 May; 67(27):1110. PubMed ID: 13667877
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of some common peripheral vascular disorders.
    ABRAMSON DI
    J Lancet; 1957 Aug; 77(8):273-7. PubMed ID: 13449420
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral vascular disease; treatment with benzyl-imidazoline.
    BUBERT JD
    Med Times; 1952 Feb; 80(2):101-2. PubMed ID: 14909988
    [No Abstract]   [Full Text] [Related]  

  • 24. [Principles and possibilities in the treatment of Sudeck's atrophy and of peripheral vascular diseases with autonomic drugs].
    GOTZE J
    Munch Med Wochenschr; 1955 Jan; 97(2):49-51. PubMed ID: 14356091
    [No Abstract]   [Full Text] [Related]  

  • 25. Roniacol timespan in the treatment of peripheral vascular and allied disorders.
    EISAMAN JL
    Curr Ther Res Clin Exp; 1960 Nov; 2():527-31. PubMed ID: 13726161
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nicotinic acid in the treatment of vascular diseases].
    NEIKES K
    Med Welt; 1960 Sep; 38():1977-84. PubMed ID: 13728206
    [No Abstract]   [Full Text] [Related]  

  • 27. Peripheral vascular care: should you have a "vascular center"?
    Sallo B
    J Cardiovasc Manag; 2004; 15(4):18-22. PubMed ID: 15315153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations.
    Hirsch AT; Haskal ZJ; Hertzer NR; Bakal CW; Creager MA; Halperin JL; Hiratzka LF; Murphy WR; Olin JW; Puschett JB; Rosenfield KA; Sacks D; Stanley JC; Taylor LM; White CJ; White J; White RA; Antman EM; Smith SC; Adams CD; Anderson JL; Faxon DP; Fuster V; Gibbons RJ; Hunt SA; Jacobs AK; Nishimura R; Ornato JP; Page RL; Riegel B; ; ; ; ;
    J Vasc Interv Radiol; 2006 Sep; 17(9):1383-97; quiz 1398. PubMed ID: 16990459
    [No Abstract]   [Full Text] [Related]  

  • 29. [Two years of experience as an adviser for patients with vascular diseases].
    PAULUS HJ
    Dtsch Gesundheitsw; 1954 Apr; 9(13):412-5. PubMed ID: 13191044
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of high doses of amygdalic ester of 3,5,5-trimethylcyclohexanol (cyclospasmol) in the treatment of peripheral vascular disorders].
    MATHIEU L; PERNOT C; METZ J; STREIFF F
    Rev Med Nancy; 1959 Mar; 84():255-67. PubMed ID: 13646365
    [No Abstract]   [Full Text] [Related]  

  • 31. [Peripheral arterial disease: where are we in 2006?].
    Sraieb T; Bougamra S; Ben Romdhane N; Longo S; Manaa J
    Tunis Med; 2007 May; 85(5):361-6. PubMed ID: 17657918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease).
    Creager MA; Goldstone J; Hirshfeld JW; Kazmers A; Kent KC; Lorell BH; Olin JW; Rainer Pauly R; Rosenfield K; Roubin GS; Sicard GA; White CJ; Creager MA; Winters WL; Hirshfeld JW; Lorell BH; Merli G; Rodgers GP; Tracy CM; Weitz HH; ; ;
    J Am Coll Cardiol; 2004 Aug; 44(4):941-57. PubMed ID: 15312891
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinogen apheresis and peripheral vascular disease: some progress?
    Schiffl H
    Blood Purif; 2007; 25(5-6):515; author reply 516. PubMed ID: 18196897
    [No Abstract]   [Full Text] [Related]  

  • 34. [Group instruction & treatment of patients with post-thrombotic disorders of the lower extremities].
    RASTGELDI S
    Sven Lakartidn; 1958 Nov; 55(46):3281-90. PubMed ID: 13615679
    [No Abstract]   [Full Text] [Related]  

  • 35. New pharmacological method with H.A.H. for the treatment of peripheral circulation disorders, nerve, muscle and joint diseases.
    SZIRMAI E
    Yokohama Med Bull; 1957 Aug; 8(4):242-4. PubMed ID: 13558213
    [No Abstract]   [Full Text] [Related]  

  • 36. The holistic approach to peripheral vascular diseases.
    OWENS JC
    Ariz Med; 1959 May; 16(5):363-9. PubMed ID: 13638095
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with the complex therapy of peripheral vascular diseases].
    ABERLE L; HAJDU J; VARGA F; SZOOR J
    Orv Hetil; 1958 Nov; 99(46):1613-5. PubMed ID: 13613803
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of peripheral circulation disorders.
    VONTOBEL W
    Praxis; 1958 Nov; 47(46):1106-9. PubMed ID: 13614166
    [No Abstract]   [Full Text] [Related]  

  • 39. Current concepts in the treatment of peripheral venous disorders.
    ROSENBERG N
    Ind Med Surg; 1958 May; 27(5):226-32. PubMed ID: 13524936
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of peripheral blood circulation disorders].
    CAITHAML W
    Wien Med Wochenschr; 1957 Jul; 107(29-30):593-7. PubMed ID: 13468486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.